
Key Outcomes
- Home
- Education
- Doctor of Pharmacy
- Key Outcomes
Key Outcomes
Licensure Exam Pass Rates (1) | ||||
---|---|---|---|---|
Year | NAPLEX Ohio State |
NAPLEX All Graduates from ACPE-accredited programs |
MPJE Ohio State |
MPJE All Graduates from ACPE-accredited programs |
2024 | 89.5% (n=114) |
77.5% (n=10,466) |
95.7% (n=69) |
78.4% (n=6,257) |
2023 | 92.5% (n=120) |
76.6% (n=12,229) |
91.2% (n=68) |
73.7% (n=7,918) |
2022 | 89.4% (n=113) |
77.4% (n=13,371) |
94.8% (n=77) |
75.6% (n=8,789) |
2021 | 86% (n=110) |
82% (n=14,013) |
87% (n=87) |
79% (n=9,178) |
Complete lists of passing rates for 2022-2024 graduates of Accreditation Council for Pharmacy Education-accredited pharmacy programs are available from the National Association of Boards of Pharmacy. Please visit NAPLEX or MPJE passing rate tables for more information.
Ohio State’s first-time test takers have exceeded the average annual pass rate for ACPE-accredited programs on the North American Pharmacist Licensure Examination® (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination® (MPJE) since 2012.
Graduation Rates (2) | ||||
---|---|---|---|---|
Class of | Four-year graduation rate | Delayed graduation for personal or academic reasons | Dismissed | Withdrew for personal or academic reasons |
2025 | 87.9% | 6.5% | 1.6% | 4.0% |
2024 | 89.7% | 4.0% | 0.0% | 6.3% |
2023 | 88.5% | 4.3% | 0.7% | 6.5% |
2022 | 93.6% | 2.4% | 0.0% | 4.0% |
2021 | 92.1% | 0.8% | 0.0% | 7.1% |
Third Professional Year Program-Level Assessment Highlights, Class of 2026 (n=115) (3)
Percentage of class passing ≥ 70% of assessments | 100% |
Percentage of class passing ≥ 80% of assessments | 96% |
Percentage of class passing ≥ 90% of assessments: | 63% |
Percentage of class passing patient communication assessments | 100% |
How did students pay for Pharmacy School (4)?
(Percentages represent the proportion of the Class of 2025 students who used each type of funding.)
Loans | 71% |
Family Support | 51% |
Scholarships | 50% |
Jobs | 45% |
Personal Savings | 33% |
Employer Tuition Assistance (With or without a future work commitment) |
7% |
Other Tuition Assistance (Sources not specified) |
1% |
Class of 2025 Post-Graduation Outcomes: May 2025 (n=114) (4)
Residency or Residency/Combined Master's | 53% |
Employment in a Pharmacy or Pharmacy-related job (full-time or part-time) | 25% |
Still Seeking a Position | 12% |
Not Yet Looking For a Position | 5% |
Fellowship | 4% |
Did Not Respond to the Survey | 1% |
Residencies 2025: Practice Settings (n=60) (4)
PGY1 Pharmacy Residency (Setting not specified) | 81% |
PGY1 Ambulatory Care Pharmacy Residency | 5% |
PGY1 Managed Care Pharmacy Residency | 3% |
PGY1 / PGY2 Residency + Master's Program | 3% |
PGY1 Community Pharmacy Residency | 2% |
PGY1/PGY2 Investigational Drug Research Residency | 2% |
PGY1 Residency + Master’s Program | 2% |
Veterinary Pharmacy Residency | 2% |
Residency Search Highlights: Class of 2025 (n=29) (4)
Combined match rate (residencies obtained within or outside the American Society of Health System Pharmacist match process) | 94% |
Percentage of applicants securing first- or second-choice residency placement | 77% |
Average residency salary | $57,050 |
Employment 2025: Practice Settings (n=29) (4)
Community Pharmacy | 66% |
Hospital Pharmacy (Inpatient or Outpatient) | 24% |
Compounding or Specialty Pharmacy | 7% |
Industry | 3% |
Employment Highlights 2025 (4)
Average number of months spent actively seeking employment (n=42) | 1.9 |
Average number of employers interviewed with (n=42) | 1.2 |
Average number of job offers received per graduate (n=31) | 1.1 |
Average starting salary reported by Ohio State graduates accepting full-time employment as a pharmacist | $116,051 |
Percentage of 2025 graduates receiving or accepting a full-time employment offer who reported a starting salary | 62% |
Percentage of graduates receiving or accepting a full-time employment offers also receiving an employment bonus offer | 22% |
Post-Graduation Placement Satisfaction 2025 (4)
“I am pleased with the offers I received.” (n=89) | 97% |
“I obtained a placement in my preferred setting in pharmacy.” (n=89) | 97% |
(1) Pass rates for 2022-2024 graduates reported by National Association of Boards of Pharmacy for the NAPLEX and MPJE. Results are for first-time test takers who are same-year graduates from Ohio State. Examinees who graduated before or after the reported years are not included. Examinees who tested before or after the reported years were not included. Only ACPE-accredited institutions are included in these pass rates. Multistate Pharmacy Jurisprudence (MPJE) exam results reflect test takers testing in the state in which their school is located.
(2) Four-year graduation rates and rates of attrition (e.g., delayed graduation, withdrawals, dismissals) are calculated as a percentage of students admitted as a cohort four years earlier, excepting students pursuing dual degrees that require more than four years to complete.
(3) The Doctor of Pharmacy curriculum includes end-of-year Program-level Assessments composed of written and performance-based assessments of critical knowledge and skills. Third-year Program-level Assessments are formative and summative assessments of student readiness to progress to advanced pharmacy practice experiences (APPEs). Results shown above are for Class of 2026 graduates, who completed these assessments in April 2025. Students were required to pass at least 11 of 16 activities to be eligible to begin APPE rotations.
(4) Results collected in an annual survey of post-graduation outcomes for Ohio State PharmD graduates. Survey administered via Qualtrics, March 31-May 31, 2025. Of 114 graduating students, 113 returned completed surveys (99% response rate). All responses to survey questions were voluntary, resulting in varying numbers of responses for each survey item.
(5) Satisfaction with post-graduation outcomes was collected with Ohio State’s PharmD postgraduation survey (see note 4, above). Percentages reported are calculated from respondents with a placement offer in hand at time of response